{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T23:07:05Z","timestamp":1778972825844,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejpb.2026.115078","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T22:21:22Z","timestamp":1776637282000},"page":"115078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Incorporation of micronized poorly soluble drug into orodispersible tablets by aqueous fluid bed granulation of co-processed excipients"],"prefix":"10.1016","volume":"224","author":[{"given":"S.","family":"Badawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Lillotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Esser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nueboldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Hoheisel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-9823","authenticated-orcid":false,"given":"J.","family":"Breitkreutz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115078_b0005","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/powders1020008","article-title":"A combined isolation and formulation approach to convert nanomilled suspensions into high drug-loaded composite particles that readily reconstitute","volume":"1","author":"Coelho","year":"2022","journal-title":"Powders"},{"key":"10.1016\/j.ejpb.2026.115078_b0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejps.2012.04.020","article-title":"Application of spray granulation for conversion of a nanosuspension into a dry powder form","volume":"47","author":"Bose","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115078_b0015","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.3390\/nano13172419","article-title":"Preparation and characterization of spray-dried hybrid nanocrystal\u2013amorphous solid dispersions (HyNASDs) for supersaturation enhancement of a slowly crystallizing drug","volume":"13","author":"Rahman","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejpb.2026.115078_b0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/pharmaceutics15010278","article-title":"The effect of the particle size reduction on the biorelevant solubility and dissolution of poorly soluble drugs with different acid-base character","volume":"15","author":"Csics\u00e1k","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115078_b0025","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/13816128113199990401","article-title":"Nanosuspensions of poorly water soluble drugs prepared by top-down technologies","volume":"20","author":"Zhang","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejpb.2026.115078_b0030","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.3390\/pharmaceutics14081688","article-title":"Evaluation of the Formulation Parameter-Dependent Redispersibility of API Nanoparticles from Fluid Bed Granules","volume":"14","author":"Wewers","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115078_b0035","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/j.2042-7158.2011.01351.x","article-title":"Bead layering as a process to stabilize nanosuspensions: influence of drug hydrophobicity on nanocrystal reagglomeration following in-vitro release from sugar beads","volume":"63","author":"Kayaert","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2026.115078_b0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijpharm.2016.09.046","article-title":"Fast dissolution of poorly water soluble drugs from fluidized bed coated nanocomposites: impact of carrier size","volume":"513","author":"Azad","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115078_b0045","doi-asserted-by":"crossref","DOI":"10.15406\/japlr.2018.07.00198","article-title":"Technologies to improve the solubility, dissolution and bioavailability of poorly soluble drugs","volume":"7","author":"Kanikkannan","year":"2018","journal-title":"J. Anal. Pharm. Res."},{"issue":"2\u20133","key":"10.1016\/j.ejpb.2026.115078_b0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0001-8686(80)85006-8","article-title":"Physical stability of suspension concentrates","volume":"12","author":"Tadros","year":"1980","journal-title":"Advances in Colloid and Interface Science"},{"key":"10.1016\/j.ejpb.2026.115078_b0055","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1002\/jps.24015","article-title":"Preparation and solidification of redispersible nanosuspensions","volume":"103","author":"Zhang","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115078_b0060","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.ces.2005.02.021","article-title":"Studies of fluid bed granulation in an industrial R&D context","volume":"60","author":"Boerefijn","year":"2005","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.ejpb.2026.115078_b0065","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.xphs.2018.09.006","article-title":"Impact of different dry and wet granulation techniques on granule and tablet properties: a comparative study","volume":"107","author":"Arndt","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115078_b0070","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1080\/03639040802005024","article-title":"Production and in vitro characterization of solid dosage form incorporating drug nanoparticles","volume":"34","author":"Basa","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2026.115078_b0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/pharmaceutics12040363","article-title":"Influence of formulation parameters on redispersibility of naproxen nanoparticles from granules produced in a fluidized bed process","volume":"12","author":"Wewers","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115078_b0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1248\/cpb.c13-00752","article-title":"Formulation design for orally disintegrating tablets containing enteric-coated particles","volume":"62","author":"Okuda","year":"2014","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ejpb.2026.115078_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120725","article-title":"Formulation and evaluation of bitter taste-masked orally disintegrating tablets of high memantine hydrochloride loaded granules coated with polymer via layering technique","volume":"604","author":"Kadota","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115078_b0090","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s11095-016-1946-9","article-title":"Pediatric dispersible tablets: a modular approach for rapid prototyping","volume":"33","author":"Buck","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115078_b0095","unstructured":"D.E. Wurster, J.A. Lindlof, Particle coating apparatus, 3,241,520, 1966."},{"key":"10.1016\/j.ejpb.2026.115078_b0100","unstructured":"European Pharmacopoeia, 10th Edition, Vol. 1. Council of Europe, Strasbourg, France, 2020, Monograph 2.9.34. Bulk Density and Tapped Density of Powders."},{"key":"10.1016\/j.ejpb.2026.115078_b0105","unstructured":"European Pharmacopoeia. 10th edition. Vol. 1. Council of Europe, Strasbourg, France, 2020. Powder flowability (2.9.36)."},{"key":"10.1016\/j.ejpb.2026.115078_b0110","unstructured":"H. Ohrem, R. Ognibene, Is another ODT excipient necessary? (2009). Pharmaceutical Technology Europe. 21. 36-43, (n.d.)."},{"key":"10.1016\/j.ejpb.2026.115078_b0115","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0009-2509(83)80042-6","article-title":"Particle growth mechanisms in fluidised bed granulation\u2014I","volume":"38","author":"Smith","year":"1983","journal-title":"Chem. Eng. Sci."},{"key":"10.1016\/j.ejpb.2026.115078_b0120","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.xphs.2017.12.002","article-title":"Understanding the factors that control the quality of mini-tablet compression: flow, particle size, and tooling dimension","volume":"107","author":"Zhao","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115078_b0125","unstructured":"S.G. Castro, M.V. Ram\u00edrez-Rigo, D.A. Allemandi, S.D. Palma, New binary solid dispersion of indomethacin and croscarmellose sodium: physical characterization and invitro dissolution enhancement., (n.d.)."},{"key":"10.1016\/j.ejpb.2026.115078_b0130","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1002\/jps.21626","article-title":"Indomethacin polymorphs: experimental and conformational analysis","volume":"98","author":"Aceves-Hernandez","year":"2009","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T22:22:20Z","timestamp":1778970140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126000998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S0939641126000998"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115078","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incorporation of micronized poorly soluble drug into orodispersible tablets by aqueous fluid bed granulation of co-processed excipients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115078"}}